Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era

Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era

Background: Immuno-oncology (IO) agents and tyrosine kinase inhibitors (TKIs) have revolutionized the treatment paradigm for metastatic renal cell carcinoma (mRCC). Data on real-world usage and outcomes are limited. Objective: To examine real-world treatment patterns and clinical outcomes for mRCC....

Full description

Bibliographic Details
Main Authors: Neil J. Shah, Sneha D. Sura, Reshma Shinde, Junxin Shi, Puneet K. Singhal, Nicholas J. Robert, Nicholas J. Vogelzang, Rodolfo F. Perini, Robert J. Motzer
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:European Urology Open Science
Subjects:
Metastatic renal cell carcinoma
Immuno-oncology
Overall survival
Time to next treatment
Time on treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168323000083

Internet

http://www.sciencedirect.com/science/article/pii/S2666168323000083

Similar Items